Amphetamine Stimulant Prodrug denied for missing prior authorization by Aetna?

Aetna's specific coverage criteria for amphetamine stimulant prodrug are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Aetna Requires Prior Authorization for Amphetamine Stimulant Prodrugs

Prior authorization (PA) is Aetna's pre-approval process for medications that require clinical review before coverage is confirmed. Stimulant prodrug formulations are frequently subject to PA because they are higher-tier, higher-cost agents within a drug class that has multiple formulary alternatives. A PA-required denial simply means the claim was submitted without first obtaining Aetna's approval — it is a process failure, not necessarily a judgment that the drug is inappropriate.

## Why This Is Fixable — and Appealable If Denied

If PA was not obtained before the prescription was filled, the immediate step is to work with your prescriber's office to submit a PA request now. For ongoing or urgent need, ask your prescriber to request expedited PA. If PA is submitted and then denied on clinical grounds, that decision triggers full appeal rights. A PA denial is a coverage determination and is subject to the same internal and external appeal process as any other denial.

## Your Federal Appeal Rights

• PA denial — internal appeal: File within the deadline on the denial notice. Aetna must respond within 15 days for pre-service or 30 days for urgent pre-service requests (expedited).
• External review (ACA §2719 / ERISA §503): If the internal PA appeal is denied, you may request independent external review within four months. An IRO decides based on the clinical record.
• Expedited PA and appeal: If waiting for PA resolution poses a serious risk to your health, request both the PA and any subsequent appeal on an expedited basis and document the clinical urgency in writing.

## Documentation to Gather for the PA Submission

1. Confirmed diagnosis — chart note with diagnostic code and current severity documentation. 2. Step-therapy and prior-treatment history — if Aetna's PA criteria require that formulary alternatives be tried first, document each: agent tried, dates, and reason for inadequacy or discontinuation. 3. Prescriber clinical-necessity statement — a detailed letter explaining why this specific formulation is medically necessary for this patient, referencing the FDA prescribing information and the patient's clinical history. 4. Aetna PA criteria checklist — call the PA line or retrieve the criteria from Aetna's provider portal; confirm your documentation addresses every line item.

## Criteria-Mapping Structure

Obtain Aetna's PA criteria for stimulant medications before submitting. Build a point-by-point response:

| PA Criterion | Documentation Submitted | |---|---| | Confirmed covered diagnosis | Chart note [date] + diagnostic code | | Formulary-preferred agents tried (if required) | [Agent, dates, outcome] | | Clinical rationale for this formulation | Prescriber letter [date] |

Submitting a complete, criteria-matched PA package on the first attempt — rather than a minimal submission — significantly reduces the likelihood of a clinical denial and the need for a full appeal.